Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
11/2007
11/01/2007CA2649845A1 Terphenyl derivatives for treatment of alzheimer' s disease
10/2007
10/31/2007EP1849762A1 Substituted biphenyl carboxylic acids and derivatives thereof
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007CN101062893A Preparation method of 2,4-dichlorin phenoxyacetic acid
10/31/2007CN100345827C Bicyclic aromatic compound
10/30/2007US7288680 Benzotropolone derivatives and modulation of inflammatory response
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288569 treating vasoconstriction by administering purified 15-epi-lipoxins compounds such as 15R-5,6,15-trihydroxy-7, 9, 13-trans-11-cis-eicosatetraenoic acid, stereoisomers and a pharmaceutically acceptable carriers
10/30/2007CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/25/2007WO2007118329A1 Methods and agents for treating tuberculosis
10/25/2007WO2007101864A3 Compounds that modulate ppar activity, their preparation and use
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847524A1 Terphenyl derivatives for treatment of Alzheimer's disease
10/24/2007EP1846354A2 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
10/24/2007CN101058538A Method of preparing aluminum citrate by clay mine
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070240609 2-hydroxy-1-(4-hydroxymethyl-phenyl)-2-methyl-propan-1-one, have higher reactivity at the benzylic hydroxy group and do not have a tendency to yellowing; photocurable composition for pigmented or non-pigmented varnish surface coatings
10/17/2007CN101056851A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/17/2007CN101056850A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/17/2007CN101056840A Alpha-ketol unstaurated fatty acid derivatives and plant growth regulators containing the same
10/17/2007CN101054345A Novel bensophenone derivatives or salts thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN100343220C Technology of preparing hdyroxy acetic acid
10/11/2007WO2007115020A2 Therapeutic prostaglandin compounds for the treatment of glaucoma
10/11/2007WO2007114223A1 Method for producing carboxylic acid compound
10/11/2007WO2007113239A1 Crystalline leukotriene b4
10/11/2007US20070238894 Method for preparing pure fenofibrate
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007CA2648162A1 Prostaglandin analogues for the treatment of glaucoma or ocular hypertension
10/10/2007CN101050173A Method for producing potassium citrate through continuous condensing crystallizing, and apparatus for realizing the method
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/09/2007CA1341557C Novel triazole and imidazole compounds
10/04/2007US20070232831 Separation of Citric Acid from Gluconic Acid in Fermentation Broth using a Weakly or Strongly Basic Anionic Exchange Resin Adsorbent
10/03/2007EP1840114A1 Crystalline Leukotriene B4
10/03/2007EP1840096A1 Intermediate film of laminated safety glass with antiglare function and novel neodymium compound
10/03/2007EP1838655A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
10/03/2007EP1838654A1 Process for the manufacture of substituted propionic acids
10/02/2007CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
09/2007
09/27/2007WO2007107869A2 Lipid derivatives
09/27/2007US20070225520 Stereoselective Synthesis of a 4,4-Disubstituted Cyclohexanepropanoic Acid
09/27/2007US20070225345 Therapeutic Substituted Cyclopentanones
09/27/2007CA2647020A1 Conjugated lipid derivatives
09/26/2007EP1836150A1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
09/26/2007EP1763499B1 New photoinitiators
09/26/2007EP1742902B1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
09/26/2007EP1323703B1 Process for producing fluorinated ester compound
09/26/2007CN101041649A Production method of reclaiming vitamin C and gulonic acid from vitamin C mother liquid
09/26/2007CN101041617A Method for producing citric acid bismuth, oxalic acid bismuth and bismuth subsalicylate by electrolyzing active metal bismuth
09/26/2007CN100339353C Preparation method and use of alpine yarrow herb ketoacid
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/25/2007US7273593 Comprising a bundle of catalyst tubes, through whose space surrounding the catalyst tubes a heat exchange medium is passed, a pump for circulating the heat exchange medium; especially for oxidation reactions
09/25/2007CA2301066C Method for purifying lactic acid
09/20/2007WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007WO2007056500A3 Compounds with activity at estrogen receptors
09/20/2007US20070219395 2-(3-Hydroxyphenoxymethyl)-6-methylbenzoic Acid as chemical intermediate for synthesizing PPAR agonists and antagonists
09/20/2007US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/19/2007EP1300386B1 Method for producing fluorine-containing compound
09/19/2007CN101037400A Preparation method of L-Ornithine-Malic Acid
09/19/2007CN100338081C Olefin oligomerization catalyst component and its preparation method and catalyst
09/19/2007CN100338009C Use of 1-methyl-4-isopropyl-bicyclo[2,2,2] octane-2,3-dicarboxylic acid
09/19/2007CN100338008C 1-carboxy-1-(3,5-dimethoxy phenyl)-2-(4-R group phenyl) ethano and preparation method thereof
09/19/2007CN100338006C Purification of alpha-, bera- or gamma-substituted carboxylic acids
09/13/2007WO2007102105A2 Method for preparing an organic amine-lactic acid complex
09/13/2007WO2007101864A2 Compounds that modulate ppar activity, their preparation and use
09/13/2007WO2007071766A3 Phenoxy acetic acids as ppar delta activators
09/13/2007US20070213348 Chemical Compounds
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070212765 water-miscible organic amine is reacted with magnesium lactate in an aqueous medium in a reactor to form the complex and precipitated magnesium hydroxide, after which the complex is cleaved into lactic acid and the water-miscible organic amine
09/13/2007CA2645719A1 Compounds that modulate ppar activity, their preparation and use
09/12/2007EP1832649A1 Method for treating wine-alcohol industry liquid discharges
09/12/2007CN101033189A Method of preparing calcium gluconate from mother liquid after gluconate delta-lactone crystallization
09/11/2007US7268249 Reacting hydroquinone or a salt thereof with a S-2-halopropanoic acid or a salt thereof in the presence of a mild reducing agent
09/11/2007US7268248 Bichlorinated compounds formed under with carboxy groupand elimation of water
09/11/2007US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents
09/11/2007US7267832 Forming a reaction mixture by reacting a calcium compound with citric acid in an aqueous solution at a temperature of less than about 10 degrees C. to form a calcium citrate, spray drying at a temperature of less than about 10 degrees C. effective to provide the amorphous water-soluble calcium citrate
09/07/2007WO2007023173A8 A process for the conversion of furfuryl alcohol into levulinic acid or alkyl levulinate
09/05/2007CN101031540A 六氟异丙醇取代的醚衍生物 Hexafluoroisopropanol substituted ether derivatives of
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101031534A Method for producing pyruvic acid
09/05/2007CN101029317A Technology for rapidly dissolving calcium citrin by potato slag
09/05/2007CN100335456C Method for preparing acyclic beta keto ester
09/04/2007US7265239 Contacting furfuryl alcohol and water or an alkyl alcohol with a porous heterogeneous strong acid ion-exchange resin that has pores with an average diameter of 1 to 1000 nm.
09/04/2007US7265143 C-4 substituted retinoids
09/04/2007US7264790 Contrast medium containing liposomes; diagnosis of vascular system disorders,cell proliferation; antitumor agents; antiinflammatory agents
09/04/2007US7264184 Birch bark processing and the isolation of natural products from birch bark
08/2007
08/30/2007US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors
08/29/2007EP1826195A1 Alpha-ketol unstaurated fatty acid derivatives and plant growth regulators containing the same
08/29/2007EP1824808A1 Process for purifying hydroxycarboxylic acid, process for producing cyclic ester, and process for producing polylhydroxycaboxylic acid
08/29/2007CN101027069A 神经酰胺酶抑制剂 Ceramidase inhibitor
08/29/2007CN100334060C Production of pyruvate from hydroxy-acetone in biomass pyrolytic water-phase product
08/23/2007WO2007033508A3 Organic compounds
08/23/2007US20070197826 Production of carbonyl fluoride
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 147